NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0527-4125-35 | 0527-4125 | HUMAN PRESCRIPTION DRUG | DRONABINOL | dronabinol | CAPSULE | ORAL | 20200210 | N/A | ANDA | ANDA207421 | Lannett Company, Inc. | DRONABINOL | 2.5 mg/1 | 60 CAPSULE in 1 BOTTLE (0527-4125-35) |
31722-961-60 | 31722-961 | HUMAN PRESCRIPTION DRUG | DRONABINOL | dronabinol | CAPSULE | ORAL | 20200210 | N/A | ANDA | ANDA207421 | Camber Pharmaceuticals Inc | DRONABINOL | 5 mg/1 | 60 CAPSULE in 1 BOTTLE (31722-961-60) |
31722-960-60 | 31722-960 | HUMAN PRESCRIPTION DRUG | DRONABINOL | dronabinol | CAPSULE | ORAL | 20200210 | N/A | ANDA | ANDA207421 | Camber Pharmaceuticals Inc | DRONABINOL | 2.5 mg/1 | 60 CAPSULE in 1 BOTTLE (31722-960-60) |
31722-962-60 | 31722-962 | HUMAN PRESCRIPTION DRUG | DRONABINOL | dronabinol | CAPSULE | ORAL | 20200210 | N/A | ANDA | ANDA207421 | Camber Pharmaceuticals Inc | DRONABINOL | 10 mg/1 | 60 CAPSULE in 1 BOTTLE (31722-962-60) |